West Pharmaceutical Services stock hits 52-week high at $338.73
West Pharmaceutical Services (WST) stock has reached a new 52-week high of $338.73, marking a 52.2% increase over the past year. The company, valued at $23.77 billion, trades at a P/E ratio of 44.67, indicating premium valuations in the healthcare equipment sector despite InvestingPro suggesting it may be overvalued. Recent positive developments include an upgrade to Overweight by Barclays, an Outperform rating from Wolfe Research, and the announcement of a new President and CEO, Michel Lagarde, effective August 31, 2026.
https://www.investing.com/news/company-news/west-pharmaceutical-services-stock-hits-52week-high-at-33873-93CH-4758310